Effect of HER2 status on risk of recurrence in women with small, node-negative breast tumours
Author:
Affiliation:
1. Department of Breast Oncology, National Kyushu Cancer Centre, 3-1-1 Notame, Minami-ku, Fukuoka 811-1395, Japan
2. Department of Pathology, National Kyushu Cancer Centre, 3-1-1 Notame, Minami-ku, Fukuoka 811-1395, Japan
Abstract
Publisher
Oxford University Press (OUP)
Subject
Surgery
Link
http://academic.oup.com/bjs/article-pdf/98/11/1561/36656712/bjs7639.pdf
Reference19 articles.
1. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less;Fisher;J Clin Oncol,2002
2. An overview of HER2;Lohrish;Semin Oncol,2001
3. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
4. Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1 N0 M0 breast cancer: a nationwide population-based study;Joensuu;Clin Cancer Res,2003
5. High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller;Gonzalez-Angulo;J Clin Oncol,2009
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Perception du pronostic des tumeurs mammaires pT1a,b pN0 par la communauté oncologique française : résultats de l’enquête nationale EURISTIC;Bulletin du Cancer;2016-02
2. Small HER2-Positive Breast Cancer: Should Size Affect Adjuvant Treatment?;Clinical Breast Cancer;2015-08
3. DEAD-box helicase DP103 defines metastatic potential of human breast cancers;Journal of Clinical Investigation;2014-08-01
4. Cancers du sein T1a,b N0 M0 (RPC 2013);Oncologie;2013-12
5. Petits cancers du sein surexprimant HER2 : quel pronostic et quel traitement adjuvant ?;Bulletin du Cancer;2013-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3